KIORA PHARMACEUTICALS INC financial data

Symbol
KPRX on Nasdaq, KPHMW on OTC
Location
Encinitas, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 611% % -49%
Debt-to-equity 41% % 36%
Return On Assets -26% % -258%
Operating Margin -55211% % -346268%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3,677,935 shares 23%
Common Stock, Shares, Outstanding 3,433,491 shares 14%
Entity Public Float $12,242,441 USD 157%
Common Stock, Value, Issued $272,006 USD 1.6%
Weighted Average Number of Shares Outstanding, Basic 4,289,853 shares 1.8%
Weighted Average Number of Shares Outstanding, Diluted 4,361,740 shares 3.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD -100%
Research and Development Expense $9,776,606 USD 39%
General and Administrative Expense $5,613,988 USD 10%
Operating Income (Loss) $8,085,670 USD -263%
Nonoperating Income (Expense) $976,359 USD 43%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $7,109,310 USD 82%
Income Tax Expense (Benefit) $1,432,825 USD
Net Income (Loss) Attributable to Parent $8,542,135 USD -254%
Earnings Per Share, Basic -3 USD/shares 37%
Earnings Per Share, Diluted -2 USD/shares 66%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,508,899 USD -2.3%
Accounts Receivable, after Allowance for Credit Loss, Current $1,213,226 USD -32%
Assets, Current $22,693,856 USD -28%
Property, Plant and Equipment, Net $101,807 USD 63%
Operating Lease, Right-of-Use Asset $318,036 USD 338%
Intangible Assets, Net (Excluding Goodwill) $6,687,100 USD 0%
Other Assets, Noncurrent $58,135 USD 95%
Assets $29,863,454 USD -22%
Accounts Payable, Current $241,471 USD -63%
Employee-related Liabilities, Current $1,178,548 USD 14%
Accrued Liabilities, Current $2,153,906 USD 26%
Liabilities, Current $2,580,360 USD -27%
Contract with Customer, Liability, Noncurrent $1,250,000 USD
Deferred Income Tax Liabilities, Net $490,690 USD -37%
Operating Lease, Liability, Noncurrent $248,239 USD 533%
Liabilities $7,452,712 USD -12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $243,708 USD -224%
Retained Earnings (Accumulated Deficit) $147,700,755 USD -6.1%
Stockholders' Equity Attributable to Parent $22,410,742 USD -25%
Liabilities and Equity $29,863,454 USD -22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,704,199 USD -120%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $2,672,782 USD
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 3,433,491 shares 14%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $21,274 USD -100%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,513,419 USD -2.3%
Deferred Tax Assets, Valuation Allowance $13,139,483 USD -60%
Deferred Tax Assets, Gross $14,344,169 USD -58%
Operating Lease, Liability $404,165 USD 456%
Lessee, Operating Lease, Liability, to be Paid $437,165 USD 433%
Property, Plant and Equipment, Gross $6,256 USD -56%
Operating Lease, Liability, Current $155,926 USD 366%
Lessee, Operating Lease, Liability, to be Paid, Year Two $136,583 USD 838%
Lessee, Operating Lease, Liability, to be Paid, Year One $172,503 USD 521%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $33,000 USD 254%
Lessee, Operating Lease, Liability, to be Paid, Year Three $85,636 USD 488%
Deferred Tax Assets, Operating Loss Carryforwards $9,240,807 USD -64%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $11,528 USD
Additional Paid in Capital $170,083,195 USD 0.64%
Depreciation, Depletion and Amortization $318 USD -93%
Deferred Tax Assets, Net of Valuation Allowance $1,204,686 USD -21%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%